Skip to main content
All lobbying filings

TARPLIN, DOWNS & YOUNG, LLC

Lobbying for GENENTECH, INC. · Leading biotechnology co. focused on medicines for serious or life threatening conditions

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income · posted Jan 20, 2026

Official filing document

 Lobbying activity 3
Budget/Appropriations

Federal budget issues

Medicare/Medicaid

MINI Act, IRA, Medicare & Medicaid payment and coverage issues, CMMI, orphan drugs

Health Issues

IRA, drug pricing and access, transparency, drug pricing in federal programs, PAPH reauthorization, supply chain

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem